Sarepta Provides Update for SRP-9001-303: ENVISION study enrollment in U.S.

June 8, 2023

On June 8, 2023, Sarepta Therapeutics shared important enrollment updates about their ENVISION study (SRP-9001-303).

Please read their Community Letter by clicking here.